Topics included cancer prevention, research on HIV and aging, and the future of HIV prevention and treatment.

Wednesday, March 2, 2022 More HIV Research Highlights from CROI 2022 with Dr. Carl Dieffenbach As the 2022 virtual Conference on Retroviruses and Opportunistic Infections came to a close last week, NIAID's Dr. Carl Dieffenbach participated in a second video conversation about key study findings presented at the major scientific meeting. Topics included cancer prevention in people with HIV, research on HIV and aging, and the future of HIV prevention and treatment. Dr. Dieffenbach is the director of the NIAID Division of AIDS. National Institute of Allergy and Infectious Diseases  |  National Institutes of Health Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact Subscriber Help. This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID).                             This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107